Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
CAMP4 Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Study of CMP-CPS-001, a Potential First-in-Class Therapeutic for Urea Cycle Disorders
Read Article
News
2024
2023
Archive
Search news articles
June 3, 2020
Aprea Therapeutics Completes Full Enrollment of Phase 3 Clinical Trial in TP53 Mutant Myelodysplastic Syndromes (MDS)
May 29, 2020
Bird Rock Bio Files IND Application for Phase 2 Study of Nimacimab for Treatment of Renal Diseases
May 28, 2020
Rallybio Further Broadens Drug Development Capabilities with Addition of Róisín Armstrong, PhD
May 28, 2020
Cabaletta Bio Announces Expansion of Sponsored Research Agreement with the University of Pennsylvania
May 27, 2020
Biodesy Announces Corporate Name Change to BlueLight Therapeutics
May 26, 2020
Vor Biopharma Adds to Leadership Team with Appointment of Chief Financial Officer
May 26, 2020
Homology Medicines Announces Peer-Reviewed Publication Describing Molecular Characterization of Precise In Vivo Nuclease-Free Gene Editing with PKU Program
May 21, 2020
scPharmaceuticals Announces Pricing of Public Offering of Common Stock
May 20, 2020
CanSino Biologics and Precision NanoSystems Announce Collaboration to Co-Develop a COVID-19 RNA Vaccine
May 20, 2020
Cidara Therapeutics Doses First Patient in Pivotal Phase 3 ReSPECT Trial of Rezafungin for Prevention of Invasive Fungal Disease in Patients Undergoing Allogeneic Blood and Marrow Transplantation
« Previous Page
1
…
54
55
56
57
58
…
118
Next Page »